Last checked at 5 Aug 2008 15:44
RNS Number : 7058A
Immupharma PLC
05 August 2008
| For Immediate Release | 5 August 2008 |
AGM Statement
ImmuPharma plc (LSE:IMM), the specialist pharmaceutical discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were passed.
For further information please contact:
ImmuPharma PLC
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080 Richard Warr, Chairman +44 20 7152 4080 Dr Robert Zimmer, President & Chief +33 389 32 76 50 Scientific Officer
Buchanan Communications +44 20 7466 5000
Lisa Baderoon Rebecca Skye Dietrich
This information is provided by RNS
The company news service from the London Stock Exchange